Finished
Postoperative Pain Management Following Robotic Assisted Sacrocolpopexy
NCT06309693 · University of Alabama at Birmingham · Updated 12 Jan 2026
- What is being tested
- Quadratus Lumborum (QL) Block; Enhanced Recovery After Surgical (ERAS) Protocol
- For
- Pelvic Organ Prolapse; Post Operative Pain
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 70 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 22 Jan 2025, ends 9 Jan 2026. Registered 13 March 2024.
- Results
- None posted yet.
In the researchers' words
In the effort to reduce postoperative opioid use, there has been increasing interest in developing multimodal pain regimens to better manage postoperative pain while minimizing opioid use and their subsequent side effects that can be detrimental to the healing process. Standard of care approaches to better manage postoperative pain include the Enhanced Recovery After Surgery (ERAS) protocol and the use of peripheral and truncal nerve blocks. Truncal nerve blocks are widely used as an additional modality to provide longer lasting postoperative analgesia and have been adopted as part of the standard of care. The goal of this clinical trial is to compare the effects of ERAS alone versus the quadratus lumborum (QL) nerve block on the postoperative pain experience for women with pelvic organ prolapse undergoing robotic assisted sacrocolpopexy. Subjects will be randomized to the ERAS protocol or the QL block. The main questions the study aims to answer are: 1) does the QL block decrease patient reported pain scores postoperatively; and 2) does the QL block decrease the amount of opioid pain medications in the immediate postoperative period? The primary outcome measure will be median patient reported pain score in the post-anesthesia care unit (PACU) following surgery.
Sites
- University of Alabama at BirminghamBirmingham, Alabama, United States
